School Drillers, Africa’s leading online education platform, today announced a major milestone: surpassing 1 million ...

The release utilizes the open-source project JSpecify for null safety and features a more modular architecture to simplify ...

Milestone Pharmaceuticals (MIST) just crossed a defining threshold, landing FDA approval for CARDAMYST nasal spray, its first commercial product for self treating paroxysmal supraventricular ...

The approval marks Cardamyst as the first FDA-approved treatment in over 30 years for more than 2 million Americans with PSVT. Cardamyst nasal spray is a novel and rapid-acting calcium channel blocker ...

Clearing clinical and regulatory hurdles in the development of a fast-acting nasal spray for a heart condition has given Milestone Pharmaceuticals its first FDA approval in its 22-year history. The ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The St. Charles-based company's ...

The FDA had previously turned back the heart rhythm nasal spray twice, once in late 2023 with a refusal to file letter and again in March this year, when it flagged manufacturing issues. More than two ...

CARDAMYST nasal spray is a novel and rapid-acting calcium channel blocker delivered when needed to treat often highly symptomatic and unpredictable episodes of PSVT. With CARDAMYST, adults with PSVT ...

(RTTNews) - Milestone Pharmaceuticals Inc. (MIST) is awaiting a pivotal U.S. FDA decision this month on the company's lead drug candidate, CARDAMYST nasal spray, for the acute treatment of paroxysmal ...

Milestone Systems announced that Thomas Jensen has stepped down as CEO, effective immediately. The company named Jeppe Frandsen as acting CEO effective December 1. Frandsen previously served as vice ...

The Houston Texans will be looking to come up big for the second straight week for a win against a divisional opponent, matching up against the Tennessee Titans in Week 11 for their second meeting of ...

Generative AI has become a key part of coding workflows, but most companies struggle to track its use, let alone its return on investment. Israeli startup Milestone hopes to help with a platform ...